Dr. Kobilka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
279 Campus Dr
# Beckman
Stanford, CA 94305Phone+1 650-723-7069
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1984 - 1987
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1981 - 1984
- Yale School of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1990 - 2026
- NC State Medical License 1984 - 1999
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
- Investigator Alumnus Howard Hughes Medical Institute, 1987
Publications & Presentations
PubMed
- 653 citationsStructure-based discovery of opioid analgesics with reduced side effectsAashish Manglik, Henry Lin, Dipendra K. Aryal, John D. McCorvy, Daniela Dengler
Nature. 2016-09-08 - 195 citationsIntracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor.Lutz Hein, K Ishii, S R Coughlin, Brian K. Kobilka
The Journal of Biological Chemistry. 1994-11-04 - 360 citationsLigand-specific regulation of the extracellular surface of a G-protein-coupled receptorMichael P. Bokoch, Yaozhong Zou, Søren G. F. Rasmussen, Corey W. Liu, Rie Nygaard
Nature. 2010-01-07
Journal Articles
- Structural Mechanisms of Selectivity and Gating in Anion ChannelrhodopsinsKarl Deisseroth, Lief E Fenno, Brian K Kobilka, Nature
- Crystal Structure of the Natural Anion-Conducting Channelrhodopsin GtACR1Lief E Fenno, Karl Deisseroth, Brian K Kobilka, Nature
- Structure of the Μ-opioid Receptor–Gi Protein ComplexBrian Kobilka, MD, Nature
Press Mentions
- WashU, Pharmacy Scientists Alter Fentanyl, Aim to Make It Less Lethal, Less AddictiveNovember 30th, 2022
- The Many Ways Stanford Medicine Is Responding to the Opioid CrisisMay 6th, 2022
- Recursion Founders Gin Fortunes as IPO Backers Shower $436M on One of the Biggest Boasts in AI -- Based on Some Very Small DealsApril 17th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: